Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LABU vs. METD: which is better?

Bottom line

LABU vs METD: the short answer

LABU (Direxion Daily S&P Biotech Bull 3X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs.

But LABU is far broader, holding 163 positions to 8 for METD, so beyond the top names it adds exposure METD doesn't have.

LABU is cheaper at 0.96% vs 1.02% — a difference of $6.00 a year per $10,000 invested.

Over one year, LABU returned +78.7% vs −17.3% for METD.

Updated Nov 19, 2026

LABU vs METD side by side

LABUMETD
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.96%1.02%
Annual cost per $10k$96$102
10-yr cost on $10k (prospectus)$1,178$1,428
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+78.7%−17.3%
5-yr return (annualized)−39.6%—
10-yr return (annualized)−20.8%—
Best quarter+161.5%+10.1%
Worst quarter−67.4%−25.5%
Net assets (fund)$494.4M$10.8M
Number of holdings1638
Portfolio turnover107%%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLABUMETDDifference
2025+78.7%−17.3%+96.0%

Source: Fund prospectus bar charts

Holdings overlap

7 of LABU's top 25 holdings also appear in METD's top 8.

Shared top holdings
HoldingLABUMETD
Dreyfus15.86%67.68%
Goldman Financial14.83%17.87%
N/a9.63%1.07%
N/a7.30%1.07%
Goldman Sachs Liq Es Fd A5.35%12.14%
N/a4.85%1.07%
N/a3.87%1.07%

Source: SEC Form N-PORT

LABU top 10

  1. Dreyfus — 15.86%
  2. Goldman Financial — 14.83%
  3. N/a — 9.63%
  4. N/a — 7.30%
  5. Goldman Sachs Liq Es Fd A — 5.35%
  6. N/a — 4.85%
  7. N/a — 3.87%
  8. Apogee Therapeutics Inc — 1.11%
  9. Oruka Therapeutics Inc — 1.03%
  10. Dianthus Therapeutics Inc — 0.96%

METD top 10

  1. Dreyfus — 67.68%
  2. Goldman Financial — 17.87%
  3. Goldman Sachs Liq Es Fd A — 12.14%
  4. Dreyfus — 3.99%
  5. N/a — 3.73%
  6. N/a — 2.57%
  7. N/a — 2.23%
  8. N/a — 1.07%

FAQ

What is the difference between LABU and METD?
LABU (Direxion Daily S&P Biotech Bull 3X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs. But LABU is far broader, holding 163 positions to 8 for METD, so beyond the top names it adds exposure METD doesn't have.
Which is cheaper, LABU or METD?
LABU has the lower expense ratio (0.96%).
Should I own both LABU and METD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.